Holoclara raises $16 million in Series A funding led by Bold Capital Partners to develop therapeutics using worms

Holoclara raises $16 million in Series A funding led by Bold Capital Partners to develop therapeutics using worms

06/27/24, 11:03 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svglos angeles
Money raised
$16 million
Industry
biotechnology
health care
Round Type
series a
Investors
Kairos Ventures, Freeflow Ventures, Endurance28, Tarrasque, Horizons Ventures, Bold Capital Partners
Biotech startup Holoclara has raised $16 million for its Series A. The funding round was led by Bold Capital Partners, with participation from Horizons Ventures, Tarrasque, Endurance28, Freeflow Ventures, and several angel investors. The company aims to develop therapeutics using worms, which have shown potential in alleviating conditions like asthma.

Company Info

Company
Holoclara
Location
los angeles, california, united states
Additional Info
Our unique discovery engine allows us to identify molecules, derived from worm species, to develop into safe, orally-available therapeutics.

Related People